These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 596160)

  • 1. Elimination of N-(2-aminoacyl)-2,6-xylidines after intravenous infusion in dogs.
    Berlin-Wahlén A; Barkus JC; Keenaghan JB; Lebeaux M; Tenthorey PA
    Acta Pharm Suec; 1977; 14(5-6):417-24. PubMed ID: 596160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure-activity relationship in various 4-substituted ajmaline derivatives].
    Femmer K; Gabsch G; Braun K
    Pharmazie; 1976; 31(1):36-9. PubMed ID: 1257277
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis, structure and pharmacology of acyl-2,6-xylidines.
    Białasiewicz W; Kwapiszewski W; Zurek E; Olczak A; Główka M; Polakowski R
    Acta Pol Pharm; 2004; 61(3):215-21. PubMed ID: 15481248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicological study of aprindine.
    Georges A; Gerin Y; Ghys A; Denef J; Heuker H; Labar N
    Arzneimittelforschung; 1973 Apr; 23(4):519-31. PubMed ID: 4740230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic characteristics and biodegradation of aprindin in man].
    Dodion L; de Suray JM; Deblecker M; Georges A
    Therapie; 1974; 29(2):221-32. PubMed ID: 4849380
    [No Abstract]   [Full Text] [Related]  

  • 7. Derivatives of (R,S)-1-N-(theophyllinyl-7'-ethyl)-amino-2-propanol with antiarrhythmic activity.
    Eckstein M; Zajaczkowska J; Samochowiec L; Maksjan M
    Pol J Pharmacol Pharm; 1990; 42(4):387-92. PubMed ID: 2097599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 9. Xylidine isomers. VII. Structure--hepatotoxic activity relationships of some xylidines.
    Weinberg J; Sahini VE
    J Theor Biol; 1981 Jan; 88(1):153-9. PubMed ID: 7266000
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of xylazine as a chemical restraining agent, sedative, and analgesic in horses.
    Hoffman PE
    J Am Vet Med Assoc; 1974 Jan; 164(1):42-5. PubMed ID: 4809846
    [No Abstract]   [Full Text] [Related]  

  • 11. New antiarrhythmic agents. 2. Amide alkyl alpha-amino xylidides.
    McMaster PD; Byrnes EW; Feldman HS; Takman BH; Tenthorey PA
    J Med Chem; 1979 Oct; 22(10):1177-82. PubMed ID: 513065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between anti-arrhythmia effect and pharmacological data of Brufacaine in parenteral and oral administration in man].
    Burhorn D; Siegers CP; Diederich KW
    Verh Dtsch Ges Inn Med; 1975; 81():187-90. PubMed ID: 1229491
    [No Abstract]   [Full Text] [Related]  

  • 14. Air cystometry in dogs under xylazine-induced restraint.
    Oliver JE; Young WO
    Am J Vet Res; 1973 Nov; 34(11):1433-5. PubMed ID: 4748727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Compounds with antiarrhythmic effects].
    Faust G; Fiedler W
    Pharmazie; 1973 Jun; 28(6):345-50. PubMed ID: 4146920
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amino acid derivatives of 2,6-xylidine and p-aminobenzoic acid. II. Synthesis of derivatives of N-(p-aminobenzoylaminoalkylacyl)-2,6-xylidines and study of their resistance to proteolytic factors].
    Kwapiszewski W; Pirianowicz-Chaber E; Skulski L
    Acta Pol Pharm; 1989; 46(5-6):418-23. PubMed ID: 2517684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of antiarrhythmic drugs.
    Kock-Weser J
    Cardiovasc Clin; 1975; 7(2):191-202. PubMed ID: 1104167
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides.
    Lindberg UH; Akerman B
    Acta Pharm Suec; 1985; 22(6):321-34. PubMed ID: 3832783
    [No Abstract]   [Full Text] [Related]  

  • 19. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conformational analysis of anti-arrhythmia agents of the lidocaine series and a model for the mechanism of their action].
    Vol'kenshteĭn MV; Golovanov IB; Grenader AK; Ermakov GL
    Biofizika; 1988; 33(6):968-72. PubMed ID: 2470414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.